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Rare diseases are difficult if not impossible to study outside of population-based
registries. Particularly in the context of rare neurodegenerative diseases characterized
by case heterogeneity, difficult differential diagnosis by specialists, and small numbers
of patients, registries make otherwise unfeasible incidence studies cost-effective and
manageable. Building up and maintaining such registries is challenging and requires
strong, active, and collaborative networks. Centralization around a leading institution
provides structure and consistency, but this single-site storage leads to inefficiency
and bottlenecks and is prone to failures, attacks, and manipulation. Furthermore, a
substantial amount of trust is required between parties sharing data in a traditional
registry. Patients are increasingly reluctant to share data in light of regular news reports
about healthcare data breaches. Underfunded rare disease specialized centers are also
hesitant to exchange with the leading institution out of fear that the low numbers
of patients may seek treatment elsewhere. A lack of electronic health records and
information system interoperability in certain settings leads to information silos and
only further exacerbate the other issues. Blockchain technology may provide unique,
innovative solutions to many of these challenges. Specifically, through digital trust and
the use of an immutable distributed ledger, automated data transaction processing,
guaranteed integrity, and enhanced security, blockchain technology seems to be
perfectly suitable to optimize current population-based rare neurodegenerative disease
registry construction and maintenance.
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INTRODUCTION
The establishment and maintenance of a population-based registry is a joint effort of a network
of facilities, general practitioners, patients’ associations, and other stakeholders, with the goal of
identifying all cases of a disease of interest in a well-defined geographic area and time interval.
Population-based registries are particularly important in the context of rare neurodegenerative
disorders (Rooney et al., 2017). These diseases are characterized by clinical heterogeneity, difficult
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differential diagnosis, unclear etiology, and low incidence and
prevalence. Thus, prospective cohort studies investigating such
conditions are generally unfeasible; they would require enormous
funding, large sample sizes, the involvement of numerous
specialized medical personnel in endpoint adjudication, and the
proactive application of countermeasures to minimize selective
enrollment and attrition (Rooney et al., 2017). However, by
combining information about the number of new disease cases
identified from the population-based registry in a specified area
and time period with information about the population size
from administrative data, it is possible to compute measures of
incidence for a theoretical “reconstructed cohort” (Logroscino
et al., 2020). In this way, population-based registries are
the only cost-effective way to estimate the incidence of rare
neurodegenerative diseases.
Population-based registries are important tools for studying
geographical disease heterogeneity and trends over time. For
example, estimates obtained from population-based registries for
Amyotrophic Lateral Sclerosis (ALS) showed that ALS incidence
varies across the world regions, and this finding informed
research hypotheses about the possible etiological factors
behind this observed geographical heterogeneity (Logroscino
and Piccininni, 2019). Furthermore, registries play an important
role in healthcare resource allocation planning (Rooney et al.,
2017). For instance, a recent study using data from a population-
based registry involving two different provinces indicated that
frontotemporal lobar degeneration, a disease generally classified
among early-onset dementias, was actually more frequent among
the Italian elderly population than expected (Logroscino et al.,
2019). Such insights can have important implications for both
research and clinical practice.
The use of population-based registries can help reduce the
risk of selection bias in data collection. Such registries improve
overall representativeness by relying on an active search strategy
using distinct referral patterns and multiple sources to collect
information about individuals suspected to have the disease of
interest (Rooney et al., 2017).
BUILDING A REGISTRY
Though beneficial once established, building a population-based
registry for rare neurodegenerative diseases is a labor-intensive
task. First, the leading institution determines all available sources
of information in the geographical region to detect cases
(Rooney et al., 2017). These include the hospital facilities,
clinical professionals, general practitioners, patient associations,
charities, pre-existing registries, and specialized centers, with
whom an individual diagnosed with or suspected to have the
disease in the defined geographic area would have contact. This
process strongly depends on the size of the area considered, the
health system organization, and intrinsic characteristics of the
disease. Once all possible referral pathways are identified, the
leading institution conducts an awareness campaign to bridge the
different data sources and build the registry network.
To increase engagement and awareness of the operators
involved, many registries offer training in data collection and
recognition of the disease, and actively promote the registry by
using invitation letters, advertisements, public events, congresses,
and similar initiatives.
In the end, only the individual operators and the contacted
institutions willing to join the study will become nodes of the
network. In turn, they actively refer all cases identified during the
study period that fulfill the diagnostic criteria and have provided
written informed consent (Rooney et al., 2017).
By using a standardized, dedicated, structured questionnaire,
registry network members can ideally provide information about
demographics, clinical history, clinical variables, risk factors, and
in settings with appropriate infrastructure, biomarkers.
Network members contribute to data entry tasks using online
interfaces, allowing for the anonymized information to be stored
in platforms fulfilling data protection standards. Data access and
availability is strictly regulated by predetermined access rights




Bringing together different healthcare providers in a network
under the coordination of one or a few leading institutions
is extremely challenging. In general, healthcare providers tend
to over-interpret laws regulating data protection (Span, 2015)
and data sharing is often limited (Ivan, 2016). A prevailing
thought is that owning data represents a competitive advantage
(Vest and Gamm, 2010; Ivan, 2016). Sharing data with other
providers, institutions, or even with the patients themselves,
is often perceived as threatening because healthcare providers
fear losing patients who seek care from other institutions and
have concerns the collected data could be misused (Ivan, 2016;
Peterson et al., 2016). These concerns are especially widespread
in the field of rare neurodegenerative diseases, in which centers
within the same region compete for the care of few patients and
struggle to secure adequate funding from the local health system.
This high level of competition along with the misconception
that medical records belong to the healthcare providers can
make potentially important referral sources reluctant to join the
registry network.
Unfortunately, in modern healthcare systems, it remains
common that information remains exclusively within the system
in which it was created. Differences between infrastructures and
data organization systems across institutions further contribute
to regional data immobility. This problem is often referred as
lack of “interoperability,” which represents a major challenge
national health infrastructure must overcome (Office of The
National Coordinator for Health Information Technology,
2014). Another issue is the lack of use of electronic health
records in many settings; relying only on paper documentation
hinders data transfer.
These factors lead to the phenomenon of “information
silos” observed in healthcare (Ivan, 2016), resulting in isolation
and underutilization of data. Information silos are particularly
dangerous for population-based registries, which depend on the
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willingness of individual registry network members to actively
participate, trust the other institutions, and share health data in
a standardized way via the integrated network.
The classic data flow scheme consists of building a centralized
data source administered by the leading institution with
compiled data transferred from the nodes of the network.
Successful exchange of health data is hindered by interoperability
differences between systems, both in terms of data structure
and data semantics (Peterson et al., 2016). The centralized
data source, itself, as well as the presence and role of the
leading institution, may be at the root of many of these
problems. First, centralization requires substantial trust in a
single institution (Peterson et al., 2016). Aside from the logistical
constraints of a single institution administrating the registry
data, which are known to lead to bottlenecks and inefficiency
(Dubovitskaya et al., 2017), such a centralized organizational
scheme introduces a single point of failure in the system that
poses a substantial security risk.
The adoption of electronic medical records initiated a new era
of progress both in clinical practice and research. Simultaneously,
however, this technology made healthcare cybersecurity a
growing concern. According to the Department of Health and
Human Services’ Office for Civil Rights, the United States
had more than 2,500 healthcare data breaches involving more
than 500 records between 2009 and 2019. In this period,
almost 190 million healthcare records were compromised, which
corresponds to almost 60% of the United States population.
Hacking has become the leading cause of healthcare data breaches
(HIPAA, 2019).
The fact that patients still experience restricted access to their
own electronic medical information, exclusively controlled by
the care provider, combined with patients’ growing concerns
for privacy and security, introduce further complications (Ivan,
2016). This is especially relevant for rare neurodegenerative
population-based registries, in which the willingness of both
healthcare providers and patients to share data is essential.
For example, the inclusion of patients’ data without informed
consent is forbidden by new data protection laws in the
European Union (Rooney et al., 2017). Such regulations have
been generally viewed as an obstacle for the long-term success
of rare neurodegenerative population-based registries in Europe,
as they have become increasingly strict in the amount, type,
and circumstances of recordable information (Rooney et al.,
2017). A similar trend has also been observed in United States’
regulations (Wilson, 2006).
By implementing newly updated data-sharing technologies to
ensure the trust of patients in their own information’s security,
the increasingly prevalent conflict between high-quality research
and data protection can be resolved (Rooney et al., 2017).
BLOCKCHAIN TO THE RESCUE
Blockchain is the technology behind Bitcoin (Nakamoto, 2008)
and all other cryptocurrencies. Since its inception, blockchain
technology has been rapidly evolving.
As a decentralized database (or distributed ledger), blockchain
allows for the storage of information on assets and transactions
in a peer-to-peer computer network. In this way, it is
possible to have a shared public registry of ownership that is
available to all blockchain network nodes, in which transactions
are stored in “blocks” of data that are then linked and
secured together in an immutable and unforgeable “chain”
through a secure cryptographic system (Nakamoto, 2008;
Radanovic´ and Likic´, 2018).
The revolutionary potential of blockchain technology
lies in its decentralization. In blockchain-based monetary
systems, money is not issued by a central authority, ownership
of the money is not verified by a central authority, and
transactions are not regulated by a central authority.
By using strict algorithms and advanced cryptographic
techniques, blockchain makes the role of an entrusted central
authority that verifies and controls money transfers and
ownership obsolete.
Instead, the central authority’s role in the blockchain
paradigm is replaced by the network. All transactions
are stored on the blockchain after being mathematically
validated and confirmed by the nodes in the peer-to-
peer blockchain network while cryptography ensures
anonymity and security of the stored transactions
(Nakamoto, 2008).
The emergence of the first blockchain technology (in the
form of Bitcoin) in 2008 was likely catalyzed by the financial
crisis, a time during which the mistrust in institutions such as
governments, corporations, and banks that are traditionally in
charge of managing, securing, and updating the financial ledger,
reached its peak.
Healthcare data transactions and financial transactions rely
on some common underlying requirements: (1) identifying
the actors involved, (2) properly recording transactions, (3)
securing transactions against possible alterations, and (4)
keeping the transactions stored in a safe, stable, and secure
infrastructure (Ivan, 2016). Currently, the majority of healthcare
data transactions occur under the mediation of a hospital that
represents the central authority (Ivan, 2016).
This framework is also typical in a rare neurodegenerative
population-based registry: the leading institution acts as the
central authority in managing transfers of data from the
nodes to the registry’s central database, and, in turn, the
nodes of the registry network act as a central authority
in the transfer of data from the patients to the individual
registry nodes.
Centralization certainly has positive aspects but also
drawbacks, as we have outlined, including reliance on trust,
inefficiency, high risk of manipulation, vulnerability to failures
and attacks, and information siloing (Ivan, 2016).
Similar to what has previously been done in the financial
sector, blockchain technology offers intriguing possibilities to
solve these issues affecting registries (Table 1). Specifically,
blockchain alleviates the need for trust in a central authority
since the blockchain is a distributed ledger, therefore no
party or institution controls it (Nakamoto, 2008; Ivan, 2016).
The transaction processing is more efficient since it is
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TABLE 1 | Potential innovative solutions for commonly encountered registry
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shareable with nodes of the
network; improved
transparency
based on digital trust. The validation is automatic and the
assets are transferred directly without intermediaries (Angraal
et al., 2017). Once transactions are validated and stored
on the blockchain, it is essentially impossible to manipulate
them, ensuring immutability, and integrity (Nakamoto, 2008;
Linn and Koo, 2016).
Furthermore, the blockchain is available to all computers
connected to the network, however, pseudo-anonymity is
guaranteed and the content of transactions can be encrypted,
which ensures both transparency and security (Ivan, 2016).
All of this is possible because blockchain uses a peer-to-
peer architecture (Linn and Koo, 2016) that is able to
“create an append-only, immutable, and timestamped chain
of content” and relies on a public key cryptography system
(Ekblaw et al., 2016).
Encrypted transactions are digitally signed, guaranteeing both
authenticity and anonymity (Nakamoto, 2008; Linn and Koo,
2016). A group of transactions is stored into a block, which is
then linked to the previous one through a cryptographic hash
function, ensuring that blocks are added in chronological order
(Nakamoto, 2008).
This continuously growing, chronologically ordered list of
blocks (“chain”) is readily shared among all the participating
nodes of the network (Angraal et al., 2017).
Participating blockchain network nodes also contribute
to the process of collectively validating and approving
the new transactions contained in newly generated blocks
(Nakamoto, 2008; Linn and Koo, 2016). New transactions
are automatically validated by the network of nodes using
a mechanism to reach consensus, which replaces the need
for trust in the central authority to conduct validity checks
(Nakamoto, 2008).
Blockchain technology offers a unique opportunity to store
healthcare data in a distributed, transparent, temporally resistant,
and secure way. This could boost efficiency and incentivize
participation in a continuous communication process among
different stakeholders.
An example of applying blockchain technology to healthcare
data is the platform MedRec (2017). This project, resulting from
a collaboration between the MIT Media Lab and the Beth Israel
Deaconess Medical Center, aims to give patients the knowledge of
who has access to their healthcare data and the power to directly
share their data and manage permissions (Angraal et al., 2017).
The fact that patients could digitally move and share all of
their own healthcare data records across different healthcare
providers in a fast, private, and secure way is attractive both for
applications in clinical practice and to improve research efficiency
(Radanovic´ and Likic´, 2018).
Therefore, we think it is crucial to evaluate further benefits and
drawbacks for the use of blockchain specifically in population-
based registries. Recent work describing the use and potential for
blockchain in healthcare (Yaeger et al., 2019) and in clinical trials




Since the emergence of blockchain technology in 2008, many
advances and variations have been proposed to handle new
challenges and allow for new applications to settings outside of
its origins in digital currency. Some of these variations may be
particularly suitable for population-based rare neurodegenerative
disease registries.
For example, the “permissioned” blockchain, in which only
specific members can validate, write, or read data transactions,
offers a more restricted structure particularly suitable for
healthcare applications (Radanovic´ and Likic´, 2018), as it
guarantees more privacy and control. On the other hand, a
permissioned blockchain architecture would require additional
challenges in the implementation and inevitably introduce a
certain level of centralization in the network. Indeed, a control
layer must be implemented to restrict permissions and access
to the ledger, implying a hierarchical architecture built on
the basis of centralized decisions. We think a particular type
of permissioned blockchain, called “consortium blockchain”
or “partially decentralized blockchain,” could be particularly
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suitable for population-based registries. In this architecture, the
consensus process is controlled only by a pre-specified set of
nodes (Vitalik Buterin, 2015) that in a population-based registry
could correspond to a group of recognized hospitals and health
organizations in the region of interest.
Moreover, clinical data could be encrypted and stored off-
chain in a “data lake” while the information necessary to
access the data could be stored on the blockchain, as in a
recently proposed architecture for healthcare aims (Linn and
Koo, 2016). Of course, the use of a data lake must be weighed
in a trade-off with corresponding losses in advantages of
proper data storage on the blockchain (Radanovic´ and Likic´,
2018). However, using an appropriate repository could allow
registries to store large amounts of data of different sizes,
circumventing problems such as scalability (Linn and Koo, 2016)
and immutable characteristic of the blockchain, the latter of
which is otherwise difficult to reconcile with strict data protection
laws (Van Humbeeck, 2017).
Blockchain technology further could ensure direct
involvement of patients in the data management process.
They could grant other parties access to their own
data (e.g., to a different doctor or another clinic) by
flexibly specifying permissions and time frames (Ivan,
2016; Linn and Koo, 2016; Yue et al., 2016). This
could also apply to consenting and providing their
data to a registry.
Bitcoin blockchain uses the highest consumption of CPU
power (one-CPU-one-vote) as mechanism to reach consensus
among blockchain network nodes (Nakamoto, 2008). This
“proof-of-work” system (Nakamoto, 2008), has been criticized,
and particularly due to its waste of energy (O’Dwyer and
Malone, 2014). Since bitcoin’s inception, other protocols for
the agreement on the validity of the transactions stored in the
blockchain between the network nodes have been proposed.
Relevant to the context of registries, the “proof-of-stake”
(QuantumMechanic, 2011) consensus mechanism lends itself
well to permissioned blockchains and is lower in costs and energy
consumption. This concept has been translated in different
ways, ranging from centralized consensus mechanisms, such
as the “proof-of-authority” (Wikipedia contributors, 2019), to
decentralized and flexible ones, such as the “pure proof-of-stake”
(Algorand, 2019).
Additional innovative features, such as the use of smart
contract technologies, are also imaginable (Radanovic´ and
Likic´, 2018). Smart contracts involve a protocol to create
self-executing digital contracts between multiple parties. These
contracts are written in a programming language and built
on a blockchain, requiring no intermediaries. The use of
this technology, which in some cases replaces legal contracts
and lawyers, could facilitate automatic patient enrollment in
population-based disease registries, provided that particular
diagnostic conditions can be automatically detected in medical
health records managed by the blockchain and previous digital
consent was obtained.
Given these innovations, we can conceptualize two
levels of distributed ledger architectures for population-
based neurodegenerative disease registry applications. First,
a lower level, in which a blockchain architecture would
be designed and built specifically for the population-
based registry use. This would allow the registry nodes
to only share data specifically collected for the purposes
of the registry, guaranteeing high-quality data collection.
Second, a higher level, in which blockchain technology
would be used to store data from electronic health
records routinely collected in clinical practice that would
integrate in real-time with the population-based registry
database. Smart contract technology could be employed to
automatically flag suspected or diagnosed cases of interest
(Yaeger et al., 2019).
CONCLUSION
Distributed ledger blockchain technology represents a unique set
of innovative, technological opportunities well suited to match
the decentralized nature of population-based registries for rare
neurodegenerative diseases. The applications we have outlined
are certainly not limited to the domain of neurodegenerative
diseases and are likely also useful for rare disease registries
in general, in which traditional centralized digital information
storage and dissemination strategies lead to a multitude of
challenges. Feasibility of the practical application of blockchain
technology in this context should be further explored.
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